Last updated on November 2017

PROJECT ID: ICN868PH-138688


Brief description of study

PROJECT ID: ICN868PH-138688

Detailed Study Description

To access the safety of oral ziprasidone over 4 weeks in the treatment of children and adolescents with Bipolar I Disorder. Will benefit from therapy with an atypical antipsychotic drug.

Clinical Study Identifier: TX3935

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

PRA Health Sciences

PRA Health Sciences
Marlton, NJ USA
  Connect »